ONC: Margin operasi BeiGene

Lambang korporat lan logo BeiGene Ltd. (ONC)

BeiGene Ltd (ONC) price action is constrained by high R&D expenditures and dependence on regulatory verdicts. However, the company effectively monetizes Brukinsa, combining Asian cost efficiencies with premium Western markets. Global reach is expanding through partnerships with industry behemoths. Operating profit margins demonstrate a current trend, where the 17.80 mark reflects fresh data on the core business's profitability.

ONC - Tingkat bathi operasi BeiGene ing rentang 04.07.2022 - 19.11.2026

Rincian metrik keuangan lan pasar BeiGene Ltd (ONC)

Analisis umum perusahaan:ONC, beigene.com
Produk merek BeiGene Oncology

Operating margin measures the share of profit from core operations before financial expenses and taxes, reflecting cost management efficiency and internal business profitability. Regular monitoring of the operating margin confirms the resilience of BeiGene Ltd. (ONC), as stable demand for therapy within the defensive oncology pharmaceutical sector offsets economic cycles and ensures a predictable cash flow.

Pesaing BeiGene Ltd

Margin dodolan operasi HALO|Rentabilitas operasi RVMD|Margin dodolan operasi AAPG (Ascentage)|Margin dodolan operasi cgoncology.com CGON|UroGen Pharma - Margin dodolan operasi|Tingkat bathi operasi BCAX|PSNL - Rentabilitas operasi|Rentabilitas kegiatan operasi Erasca Oncology ERAS|delcath.com (DCTH) - Rentabilitas operasi|Y-mAbs Therapeutics - Tingkat bathi operasi|AURA (Aura Biosciences Inc) - Margin operasi|Rentabilitas dodolan operasi candeltx.com CADL|Margin operasi ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tingkat bathi operasi|Rentabilitas operasi Actuate Therapeutics, Inc. ACTU|citiusonc.com - Rentabilitas operasi|TuHURA Biosciences Inc. - Margin operasi|TARA - Margin operasi|FATE (Fate Therapeutics) - Margin dodolan operasi|Margin dodolan operasi Aadi Bioscience, Inc.|Margin dodolan operasi TCRX|Rentabilitas operasi CSBR|Margin operasi XBIT|Rentabilitas kegiatan operasi CEL-SCI Corp.|Rentabilitas operasi ostherapies.com OSTX|RADX: Rentabilitas dodolan miturut bathi operasi|ARTV: Margin dodolan operasi|ANL (Adlai Nortye) - Rentabilitas dodolan miturut bathi operasi|Veru (VERU) - Rentabilitas operasi|Margin dodolan operasi Tempest Therapeutics Inc|Rentabilitas operasi Xilio Therapeutics|Rentabilitas dodolan miturut bathi operasi RENB (Renovaro Inc.)|Rentabilitas operasi Mural Oncology PLC (MURA)|Margin operasi Kairos Pharma (KAPA)|Rentabilitas operasi onkuretherapeutics.com OKUR|GDTC: Rentabilitas dodolan miturut bathi operasi|CRIS: Margin dodolan operasi|apollomicsinc.com (APLM) - Margin dodolan operasi|THAR: Margin operasi|Margin dodolan operasi Advanced Biomed Inc.|Margin dodolan operasi GNPX|Rentabilitas dodolan miturut bathi operasi CLDI (Calidi Biotherapeutics)|Margin operasi SBFM|Xenetic Biosciences, Inc. - Rentabilitas dodolan miturut bathi operasi|Rentabilitas operasi Salarius Pharmaceuticals SLRX|Margin operasi purple-biotech.com PPBT|AONC - Rentabilitas operasi|BGNE: Rentabilitas operasi|CKPT: Margin operasi|Elevation Oncology - Tingkat bathi operasi|ICAD (iCAD) - Margin operasi|IKNA: Tingkat bathi operasi|Rentabilitas operasi Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Tingkat bathi operasi|Rentabilitas operasi MorphoSys Corporation MOR|NAYA: Rentabilitas dodolan miturut bathi operasi|Ascentage Pharma Group International - Margin operasi